What this medicine is used for

(ARTG)

As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS). INDICATIONS AS AT 23 JANUARY 2004: As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/L) serum cholesterol levels. PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). PRAVASTATIN-WGR is indicated as an adjunct to diet and lifestyle modification for the treatment of Heterozygous Familial Hypercholesterolaemia in children and adolescent patients aged 8 Years and older (see CLINICAL TRAILS).

How to use this medicine

(ARTG)

This medicine contains one component only.

Storage conditions

(ARTG)

• Store below 25 degrees Celsius
• Protect from Light
• Protect from Moisture
• Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

• 100 tablets pack
• 3 tablets pack
• 30 tablets pack

Is this medicine subsidised ?

(PBS)

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient pravastatin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What this medicine is used for

(ARTG)

As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (eg, poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysprotenemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. INDICATIONS AS AT 20 AUGUST 1996: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia, (e.g. poorly controlled diabetes mellitus, hypothroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. INDICATIONS AS AT 2 MARCH 1999: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS). INDICATIONS AS AT 4 AUGUST 1999: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. PRAVASTATIN-STR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS).PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). INDICATIONS AS AT 23 JANUARY 2004: As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/L) serum cholesterol levels. PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). PRAVASTATIN-WGR is indicated as an adjunct to diet and lifestyle modification for the treatment of Heterozygous Familial Hypercholesterolaemia in children and adolescent patients aged 8 Years and older (see CLINICAL TRAILS).

How to use this medicine

(ARTG)

This medicine contains one component only.

Storage conditions

(ARTG)

• Store below 25 degrees Celsius
• Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

• 3 tablets pack
• 30 tablets pack
• 5 tablets pack
• 7 tablets pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient pravastatin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What this medicine is used for

(ARTG)

As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS). INDICATIONS AS AT 23 JANUARY 2004: As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/L) serum cholesterol levels. PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). PRAVASTATIN-WGR is indicated as an adjunct to diet and lifestyle modification for the treatment of Heterozygous Familial Hypercholesterolaemia in children and adolescent patients aged 8 Years and older (see CLINICAL TRAILS).

How to use this medicine

(ARTG)

This medicine contains one component only.

Storage conditions

(ARTG)

• Store below 25 degrees Celsius
• Protect from Light
• Protect from Moisture
• Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

• 100 tablets pack
• 3 tablets pack
• 30 tablets pack

Is this medicine subsidised ?

(PBS)

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient pravastatin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What this medicine is used for

(ARTG)

As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS). INDICATIONS AS AT 23 JANUARY 2004: As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/L) serum cholesterol levels. PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). PRAVASTATIN-WGR is indicated as an adjunct to diet and lifestyle modification for the treatment of Heterozygous Familial Hypercholesterolaemia in children and adolescent patients aged 8 Years and older (see CLINICAL TRAILS).

How to use this medicine

(ARTG)

This medicine contains one component only.

Storage conditions

(ARTG)

• Store below 25 degrees Celsius
• Protect from Light
• Protect from Moisture
• Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

• 100 tablets pack
• 3 tablets pack
• 30 tablets pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient pravastatin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What this medicine is used for

(ARTG)

As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS). INDICATIONS AS AT 23 JANUARY 2004: As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/L) serum cholesterol levels. PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). PRAVASTATIN-WGR is indicated as an adjunct to diet and lifestyle modification for the treatment of Heterozygous Familial Hypercholesterolaemia in children and adolescent patients aged 8 Years and older (see CLINICAL TRAILS).

How to use this medicine

(ARTG)

This medicine contains one component only.

Storage conditions

(ARTG)

• Store below 25 degrees Celsius
• Protect from Light
• Protect from Moisture
• Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

• 100 tablets pack
• 3 tablets pack
• 30 tablets pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient pravastatin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What this medicine is used for

(ARTG)

As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (eg, poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysprotenemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. INDICATIONS AS AT 20 AUGUST 1996: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia, (e.g. poorly controlled diabetes mellitus, hypothroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. INDICATIONS AS AT 2 MARCH 1999: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS). INDICATIONS AS AT 4 AUGUST 1999: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. PRAVASTATIN-STR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS).PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). INDICATIONS AS AT 23 JANUARY 2004: As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/L) serum cholesterol levels. PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). PRAVASTATIN-WGR is indicated as an adjunct to diet and lifestyle modification for the treatment of Heterozygous Familial Hypercholesterolaemia in children and adolescent patients aged 8 Years and older (see CLINICAL TRAILS).

How to use this medicine

(ARTG)

This medicine contains one component only.

Storage conditions

(ARTG)

• Store below 25 degrees Celsius
• Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

• 3 tablets pack
• 30 tablets pack
• 5 tablets pack
• 7 tablets pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient pravastatin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What this medicine is used for

(ARTG)

As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS). INDICATIONS AS AT 23 JANUARY 2004: As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/L) serum cholesterol levels. PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). PRAVASTATIN-WGR is indicated as an adjunct to diet and lifestyle modification for the treatment of Heterozygous Familial Hypercholesterolaemia in children and adolescent patients aged 8 Years and older (see CLINICAL TRAILS).

How to use this medicine

(ARTG)

This medicine contains one component only.

Storage conditions

(ARTG)

• Store below 25 degrees Celsius
• Protect from Light
• Protect from Moisture
• Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

• 100 tablets pack
• 3 tablets pack
• 30 tablets pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient pravastatin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What this medicine is used for

(ARTG)

As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (eg, poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysprotenemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. INDICATIONS AS AT 20 AUGUST 1996: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia, (e.g. poorly controlled diabetes mellitus, hypothroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. INDICATIONS AS AT 2 MARCH 1999: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS). INDICATIONS AS AT 4 AUGUST 1999: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. PRAVASTATIN-STR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS).PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). INDICATIONS AS AT 23 JANUARY 2004: As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/L) serum cholesterol levels. PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). PRAVASTATIN-WGR is indicated as an adjunct to diet and lifestyle modification for the treatment of Heterozygous Familial Hypercholesterolaemia in children and adolescent patients aged 8 Years and older (see CLINICAL TRAILS).

How to use this medicine

(ARTG)

This medicine contains one component only.

Storage conditions

(ARTG)

• Store below 25 degrees Celsius
• Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

• 3 tablets pack
• 30 tablets pack
• 5 tablets pack
• 7 tablets pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient pravastatin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What this medicine is used for

(ARTG)

As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (eg, poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysprotenemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. INDICATIONS AS AT 20 AUGUST 1996: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia, (e.g. poorly controlled diabetes mellitus, hypothroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. INDICATIONS AS AT 2 MARCH 1999: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS). INDICATIONS AS AT 4 AUGUST 1999: As an adjunct to diet for the treatment of hypercholesterolaemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. PRAVASTATIN-STR is indicated in patients with previous myocardial infarction and average (normal) serum cholesterol levels (see CLINICAL TRIALS).PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). INDICATIONS AS AT 23 JANUARY 2004: As an adjunct to diet for the treatment of hypercholesterolemia. Prior to initiating therapy with pravastatin, secondary causes of hypercholesterolemia (e.g. poorly controlled diabetes mellitus, hypothyrodism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alchoholism) should be identified and treated. PRAVASTATIN-WGR is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/L) serum cholesterol levels. PRAVASTATIN-WGR is indicated in patients with unstable angina pectoris (see CLINICAL TRIALS). PRAVASTATIN-WGR is indicated as an adjunct to diet and lifestyle modification for the treatment of Heterozygous Familial Hypercholesterolaemia in children and adolescent patients aged 8 Years and older (see CLINICAL TRAILS).

How to use this medicine

(ARTG)

This medicine contains one component only.

Storage conditions

(ARTG)

• Store below 25 degrees Celsius
• Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

• 3 tablets pack
• 30 tablets pack
• 5 tablets pack
• 7 tablets pack

Is this medicine subsidised ?

(PBS)

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient pravastatin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.